Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
5.39
+0.39 (7.80%)
At close: Aug 12, 2026, 4:00 PM EDT
5.44
+0.05 (0.93%)
After-hours: Aug 12, 2026, 6:21 PM EDT
Unicycive Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $30 | Buy | Reiterates | $30 | +456.59% | Jul 9, 2026 |
| Noble Financial | Noble Financial | Buy Reiterates $60 → $50 | Buy | Reiterates | $60 → $50 | +827.64% | Jul 1, 2026 |
| Benchmark Co. | Benchmark Co. | Buy Maintains $18 → $13 | Buy | Maintains | $18 → $13 | +141.19% | Jul 1, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $37 | Buy | Maintains | $37 | +586.46% | Jul 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15 | Buy | Reiterates | $15 | +178.29% | Jul 1, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $22 | Buy | Maintains | $22 | +308.16% | Jun 30, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $90 | Buy | Maintains | $90 | +1,569.76% | Jun 2, 2026 |
Unknown Analyst Westpark Capital No rating | Westpark Capital | Buy Initiates $72 | Buy | Initiates | $72 | +1,235.81% | Feb 20, 2026 |